| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aim Immunotech Inc. (AIM) has 5 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. AIM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.97M | $1.08M | - | |
| Dir | 521.7K | $286.9K | - | |
| COO | 401.8K | $221.0K | - | |
| CEO | 63.9K | $35.2K | - | |
| Dir | 28.4K | $15.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | Mitchell William M | Director | Sell | 4,580 | $0.19 | $883.94 | -3.7% | |
| Dec 18, 2024 | Equels Thomas K | CEO &President | Buy | 22,727 | $0.21 | $4,681.76 | +1.4% | |
| Dec 2, 2024 | Appelrouth Stewart | Director | Buy | 11,112 | $0.21 | $2,355.74 | +1.6% | |
| Nov 21, 2024 | Equels Thomas K | CEO &President | Buy | 20,000 | $0.21 | $4,240.00 | +1.2% | |
| Nov 20, 2024 | Equels Thomas K | CEO &President | Buy | 85,000 | $0.20 | $16,915.00 | +5.5% | |
| Nov 20, 2024 | Equels Thomas K | CEO &President | Buy | 60,110 | $0.18 | $11,000.13 | +4.0% | |
| Nov 20, 2024 | Appelrouth Stewart | Director | Buy | 81,953 | $0.19 | $15,816.93 | +34.2% | |
| Sep 16, 2024 | Equels Thomas K | CEO &President | Buy | 5,000 | $0.30 | $1,515.00 | +0.3% | |
| Sep 13, 2024 | Equels Thomas K | CEO &President | Buy | 20,000 | $0.31 | $6,160.00 | +1.4% | |
| May 6, 2024 | Equels Thomas K | CEO &President | Buy | 61,729 | $0.41 | $25,000.25 | +8.6% |